О компании

T3D Therapeutics is a developer of a novel drug therapy intended to stop or reverse the course of Alzheimer's disease. The company's drug is an orally-delivered once-a-day medicine that targets both the brain 'starvation' and neurodegeneration of Alzheimer's disease and helps in treating multiple manifestations of the disease, providing Alzheimer patients with a drug to potentially improve multiple defects and improve memory, motor function and cognition. T3D Therapeutics is based in Durham, North Carolina, and was founded in 2013.

US
Неизвестно
Не проверенная компания